Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 51Colorectal Neoplasms 44Carcinoma, Hepatocellular 36Rectal Neoplasms 26Lung Neoplasms 23Colonic Neoplasms 22Neoplasm Metastasis 18Esophageal Neoplasms 18Cholangiocarcinoma 15Breast Neoplasms 13Stomach Neoplasms 12Glioma 11Ovarian Neoplasms 10Melanoma 10Carcinoma, Non-Small-Cell Lung 10Carcinoma, Renal Cell 9Anus Neoplasms 9Sarcoma 8Uterine Cervical Neoplasms 7Prostatic Neoplasms 7Medulloblastoma 7Lymphoma, Non-Hodgkin 7Ependymoma 7Carcinoma, Transitional Cell 7Brain Neoplasms 7Adenocarcinoma Of Esophagus 7Wilms Tumor 6Rhabdomyosarcoma 6Rhabdoid Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6

Interventions

Taxes 1Specimen Handling 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Catheter Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Cystic Neoplasm × Magnetic Resonance Spectroscopy × Gastrointestinal × Clear all
NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡